Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial
佐贝妥昔单抗联合卡泊芬净治疗CLDN18.2阳性胃或胃食管交界处腺癌:一项随机、3期GLOW试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-023-02465-7
Shah, Manish A; Shitara, Kohei; Ajani, Jaffer A; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Gallego Plazas, Javier; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua